FDA Inspection 1076980 — Tris Pharma Inc.

Tris Pharma Inc. — FEI 3004712471

The FDA completed an inspection of Tris Pharma Inc. on Jan 23, 2019 in Monmouth Junction, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Jan 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Monmouth Junction, NJ (United States)

Citations

IDCFRDescription
191221 CFR 211.166(a)Written program not followed
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.